<DOC>
	<DOCNO>NCT02291549</DOCNO>
	<brief_summary>The RESOLVE II Study randomize , single-blind , parallel arm , concurrently control , multicenter study 300 chronic sinusitis patient prior endoscopic sinus surgery present recurrent sinus obstruction .</brief_summary>
	<brief_title>Clinical Evaluation Safety Efficacy S8 Sinus Implant Chronic Sinusitis Patients</brief_title>
	<detailed_description>The RESOLVE II Study randomize , single-blind , parallel arm , concurrently control , multicenter trial conduct 45 clinical center ( academic private ) across United States 300 adult chronic sinusitis , indicated revision surgery recur nasal obstruction/congestion symptom bilateral ethmoid polyposis .</detailed_description>
	<mesh_term>Sinusitis</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Nasal Polyps</mesh_term>
	<mesh_term>Mometasone Furoate</mesh_term>
	<criteria>Key inclusion criterion : Confirmed diagnosis chronic sinusitis Previous endoscopic sinus surgery ( ESS ) include bilateral total ethmoidectomy Nasal obstruction/congestion symptom despite use intranasal steroid irrigation spray Indication repeat ESS : Complaints least 2 symptom chronic sinusitis : nasal obstruction/congestion , postnasal discharge , thick nasal discharge , facial pain/pressure , decrease sense smell Endoscopic evidence bilateral sinus obstruction due polyposis ( minimum grade 2 side ) History highdose steroid use and/or sinus steroid irrigation within precede 1 year Key exclusion criterion : Patient presence polyposis grade 1 , 1.5 4 either side Patient presence adhesions/synechiae grade 3 4 Patient know history immune deficiency Patient concurrent condition cancer HIV require active chemotherapy and/or immunotherapy management disease Patient oralsteroid dependent condition COPD , asthma condition Patient know history allergy intolerance corticosteroid mometasone furoate Patient presence physical obstruction would preclude access either ethmoid sinus implant delivery ( e.g. , severe septal deviation , septal spur , small middle meatus , total obstruction nasal passage severe scarring , polyposis ) Patient clinical evidence acute bacterial sinusitis Patient clinical evidence suspicion invasive fungal sinusitis Patient evidence disease condition expect compromise survival ability complete followup assessment 90day followup period Patient currently participate another clinical trial already participate clinical trial Patient history insulin dependent diabetes mellitus Patient previously undergone ESS experience cerebrospinal fluid ( CSF ) leak residual compromise vision result complication prior ESS procedure Patient know dehiscence lamina papyracea Patient evidence active viral illness Patient know history diagnosis glaucoma ocular hypertension ( prior ocular exam IOP &gt; 21 mm Hg pressure lower medication give ) posterior subcapsular cataract</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>